Clinical Practice Guidelines for the Management of Type 2 Diabetes in South Asia: A Systematic Review

IF 4.3 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes & Metabolic Syndrome-Clinical Research & Reviews Pub Date : 2024-07-01 DOI:10.1016/j.dsx.2024.103094

Alina Pervez , Areesha Ahmer , Omar Mahmud , Russell Seth Martins , Hawra Hussain , Sameen Nasir , Sonia Pirzada , Mohsin Ali Mustafa , Uswah Siddiqi , Maheen Zakaria , Nashia Ali Rizvi , Ainan Arshad , Adil H. Haider , Sarah Nadeem

{"title":"Clinical Practice Guidelines for the Management of Type 2 Diabetes in South Asia: A Systematic Review","authors":"Alina Pervez , Areesha Ahmer , Omar Mahmud , Russell Seth Martins , Hawra Hussain , Sameen Nasir , Sonia Pirzada , Mohsin Ali Mustafa , Uswah Siddiqi , Maheen Zakaria , Nashia Ali Rizvi , Ainan Arshad , Adil H. Haider , Sarah Nadeem","doi":"10.1016/j.dsx.2024.103094","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Clinical practice guidelines (CPGs) are a helpful tool for the evidence-based management of Type 2 Diabetes Mellitus (T2D). The aim of this systematic review was to synthesize and appraise the scope and quality of South Asian T2D CPGs.</p></div><div><h3>Methods</h3><p>This PROPSERO registered (CRD42023425150) systematic review adhered to the 2020 PRISMA guidelines. We searched the PubMed, Embase, Cochrane, and Google Scholar databases for relevant guidelines. Data synthesis was performed using a qualitative approach and methodological quality was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool.</p></div><div><h3>Results</h3><p>We identified eleven unique CPGs (three each from Pakistan and Sri Lanka, two from India, and one each from Bangladesh, Nepal, and Bhutan) which were published or updated between 2017 and 2023. The CPGs included recommendations regarding screening, diagnosis, prevention, and management of T2D and its acute and chronic complications, comorbidities, and fasting with T2D. The AGREE II mean domain scores ranged from 37 % to 80 %; three CPGs were ‘recommended for clinical use,’ seven were ‘recommended for use with modifications’ and one was deemed unfit for implementation.</p></div><div><h3>Conclusion</h3><p>The present review summarized and appraised broadly CPGs from South Asia for T2D and can help direct improvements to future iterations.</p></div>","PeriodicalId":48252,"journal":{"name":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","volume":"18 7","pages":"Article 103094"},"PeriodicalIF":4.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871402124001553","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Clinical practice guidelines (CPGs) are a helpful tool for the evidence-based management of Type 2 Diabetes Mellitus (T2D). The aim of this systematic review was to synthesize and appraise the scope and quality of South Asian T2D CPGs.

Methods

This PROPSERO registered (CRD42023425150) systematic review adhered to the 2020 PRISMA guidelines. We searched the PubMed, Embase, Cochrane, and Google Scholar databases for relevant guidelines. Data synthesis was performed using a qualitative approach and methodological quality was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool.

Results

We identified eleven unique CPGs (three each from Pakistan and Sri Lanka, two from India, and one each from Bangladesh, Nepal, and Bhutan) which were published or updated between 2017 and 2023. The CPGs included recommendations regarding screening, diagnosis, prevention, and management of T2D and its acute and chronic complications, comorbidities, and fasting with T2D. The AGREE II mean domain scores ranged from 37 % to 80 %; three CPGs were ‘recommended for clinical use,’ seven were ‘recommended for use with modifications’ and one was deemed unfit for implementation.

Conclusion

The present review summarized and appraised broadly CPGs from South Asia for T2D and can help direct improvements to future iterations.

查看原文本刊更多论文

南亚 2 型糖尿病管理临床实践指南：系统回顾。

背景：临床实践指南（CPG）是对 2 型糖尿病（T2D）进行循证管理的有效工具。本系统综述旨在综合评估南亚 T2D CPGs 的范围和质量：本系统综述已在 PROPSERO 注册（CRD42023425150），符合 2020 年 PRISMA 指南。我们在 PubMed、Embase、Cochrane 和 Google Scholar 数据库中检索了相关指南。数据综合采用定性方法，方法学质量采用研究与评价指南评估（AGREE）II工具进行评估：我们确定了 11 份独特的 CPG（巴基斯坦和斯里兰卡各 3 份，印度 2 份，孟加拉国、尼泊尔和不丹各 1 份），这些 CPG 在 2017 年至 2023 年期间发布或更新。这些 CPG 包括有关 T2D 及其急性和慢性并发症、合并症以及 T2D 禁食的筛查、诊断、预防和管理的建议。AGREE II 的平均领域得分从 37% 到 80% 不等；3 份 CPGs 被 "建议用于临床"，7 份被 "建议在修改后使用"，1 份被认为不适合实施：本综述对南亚地区针对 T2D 的 CPG 进行了广泛的总结和评估，有助于指导今后的迭代改进。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes & Metabolic Syndrome-Clinical Research & Reviews ENDOCRINOLOGY & METABOLISM-

CiteScore

22.90

自引率

2.00%

发文量

248

审稿时长

51 days

期刊介绍： Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia. It aims to provide a global platform for healthcare professionals, diabetes educators, and other stakeholders to submit their research on diabetes care. Types of Publications: Diabetes and Metabolic Syndrome: Clinical Research and Reviews publishes peer-reviewed original articles, reviews, short communications, case reports, letters to the Editor, and expert comments. Reviews and mini-reviews are particularly welcomed for areas within endocrinology undergoing rapid changes.